YKL118W is a putative uncharacterized protein encoded by the YKL118W gene in Saccharomyces cerevisiae.
Gene Location: Chromosome XI (yeast genome).
Sequence Overlap: Partially overlaps with the VPH2 gene, which encodes a vacuolar ATPase assembly factor .
Western Blot: Used to identify YKL118W in yeast lysates, with validation against recombinant antigen .
Immunofluorescence: Potential for subcellular localization studies in yeast (though limited published data).
Co-IP Applications: Could be paired with proteins like Vph2p (vacuolar ATPase) to investigate functional pathways .
Yeast Vacuolar Studies: YKL118W’s proximity to VPH2 suggests a role in vacuolar ATPase assembly or membrane trafficking , a pathway critical for organelle acidification .
Antibody Validation Challenges: Highlighted by studies like YCharOS, which emphasize the need for rigorous characterization to avoid non-specific binding in assays like WB .
Functional Insights: While YKL118W’s exact role remains uncharacterized, its genomic context near VPH2 implies involvement in vacuolar pH regulation .
Technical Utility: The antibody’s high sensitivity (1:64,000 ELISA titer) makes it suitable for low-abundance protein detection .
Uncharacterized Epitopes: The antibody’s binding epitopes are not yet mapped.
Expanded Applications: Potential for use in flow cytometry or yeast knockout (KO) validation studies, pending further validation.
YKL118W refers to a specific open reading frame in Saccharomyces cerevisiae (baker's yeast) strain ATCC 204508/S288c, encoding a protein with UniProt accession number P36072. This protein is part of the comprehensive yeast proteome studies that help understand fundamental cellular processes through this model organism. The systematic name follows the standard yeast genome nomenclature where "Y" indicates yeast, "K" represents chromosome XI, "L" signifies the left arm of the chromosome, and "118W" denotes the specific open reading frame position and orientation (where W indicates Watson strand direction) . Studies focusing on YKL118W contribute to our understanding of basic eukaryotic cellular mechanisms that may have implications for human biology, given the high degree of conservation in fundamental cellular processes between yeast and humans.
The YKL118W antibody is commonly employed in several experimental techniques:
Western blotting - For specific detection of the YKL118W protein in cell lysates
Immunoprecipitation - To isolate the protein and its complexes from cell extracts
Immunocytochemistry - For visualizing protein localization within yeast cells
ChIP assays - If the protein has DNA-binding capabilities
Protein-protein interaction studies - Using co-immunoprecipitation methods
Researchers should optimize antibody dilutions for each application, typically starting with manufacturer recommendations (such as 1:1000 for Western blots) and adjusting based on signal strength and background levels. Most protocols require verification using appropriate positive and negative controls to ensure antibody specificity in the particular experimental context .
To maintain optimal activity of YKL118W antibodies:
Store antibody aliquots at -20°C for long-term storage (up to 1 year) or at 4°C for short-term use (1-2 weeks)
Avoid repeated freeze-thaw cycles by preparing working aliquots (typically 10-20 μL)
When thawing, allow the antibody to equilibrate slowly on ice rather than at room temperature
Always centrifuge the antibody vial briefly before opening to collect liquid at the bottom
Handle with powder-free gloves to prevent contamination
Monitor storage conditions regularly using temperature logs
Antibody solutions typically contain preservatives like sodium azide, which can inhibit peroxidase enzymes used in some detection systems. When using HRP-based detection systems, ensure any sodium azide is sufficiently diluted (typically 1:10,000 or more) to prevent interference with enzymatic activity .
Optimization of YKL118W immunodetection requires systematic approach:
Extraction buffer selection: For membrane-associated or hard-to-extract yeast proteins, compare RIPA buffer (more stringent) with gentler NP-40 or Triton X-100 based buffers. Include protease inhibitor cocktails specifically optimized for yeast (containing PMSF, pepstatin A, leupeptin, and aprotinin).
Sample preparation adjustments: For different genetic backgrounds:
| Yeast Strain | Recommended Lysis Method | Special Considerations |
|---|---|---|
| S288C (standard) | Glass bead homogenization | Standard protocol |
| W303 | Glass bead homogenization | May require 10% longer lysis time |
| Σ1278b | Enzymatic digestion + bead beating | Cell wall differences require modified approach |
| Industrial strains | Pressure-based homogenization | Thicker cell walls need more rigorous disruption |
Blocking optimization: Test 5% non-fat milk against 3-5% BSA in TBS-T to determine which provides lowest background with YKL118W antibody.
Signal enhancement techniques: For low-abundance expression, consider using signal amplification systems like biotin-streptavidin or tyramide signal amplification.
Validation across strains: Always confirm antibody specificity in each new genetic background by including a ΔykL118W deletion strain as negative control .
When using YKL118W antibody in complex systems, researchers should address several cross-reactivity concerns:
Homologous protein detection: The antibody may cross-react with proteins containing similar epitopes. Conduct BLAST analysis of the immunizing peptide sequence against the proteome of your experimental system to identify potential cross-reactive proteins.
Species cross-reactivity assessment: If working with other yeast species (like Candida or Schizosaccharomyces), perform epitope conservation analysis. Sequence alignment of the target region can predict likely cross-reactivity:
| Species | Sequence Homology to Target Epitope | Expected Cross-Reactivity |
|---|---|---|
| S. cerevisiae | 100% (target) | High |
| S. paradoxus | ~90% (typical) | Moderate to High |
| S. bayanus | ~70% (typical) | Low to Moderate |
| C. albicans | <50% (typical) | Minimal |
Pre-adsorption testing: For critical experiments, pre-adsorb the antibody with recombinant related proteins to remove cross-reactive antibodies.
Two-antibody verification: When possible, confirm results using a second antibody raised against a different epitope of YKL118W .
When experiencing inconsistent results with YKL118W antibody:
Systematic signal variation analysis:
Document all variables between successful and unsuccessful experiments
Test new and old antibody lots side-by-side
Verify protein extraction efficiency using total protein stains
Protocol modification hierarchy:
| Issue | First-line Adjustment | Second-line Adjustment | Third-line Adjustment |
|---|---|---|---|
| Weak signal | Increase antibody concentration | Extend primary antibody incubation time | Switch detection system |
| High background | Increase blocking time/concentration | Add 0.1-0.5% Tween-20 to washing buffer | Pre-adsorb antibody with cell lysate |
| Multiple bands | Increase stringency of washing | Add detergents to reduce non-specific binding | Optimize blocking agent |
| Inconsistent results | Standardize lysate preparation | Aliquot antibody to prevent freeze-thaw | Use automated systems if available |
Epitope masking investigation: If protein modifications affect antibody recognition, try:
Dephosphorylation treatment before SDS-PAGE
Testing both native and denatured detection methods
Using epitope retrieval techniques for fixed samples
Interference elimination: For complex samples, consider immunoprecipitation before detection to reduce matrix effects and concentrate the target protein .
For accurate quantification of YKL118W protein levels:
Standardized loading controls:
Use multiple loading controls (e.g., Pgk1, Act1, and a total protein stain)
Validate that loading controls are not affected by your experimental conditions
Densitometry best practices:
Use a wide dynamic range imaging system (16-bit minimum)
Ensure all bands fall within the linear range of detection
Subtract local background individually for each lane
Normalize to multiple references using geometric averaging
Statistical analysis approach:
| Experimental Design | Recommended Statistical Test | Minimum Sample Size |
|---|---|---|
| Two conditions | Student's t-test or Mann-Whitney | n=3 biological replicates |
| Multiple conditions | ANOVA with post-hoc tests | n=3-4 biological replicates |
| Time-course | Repeated measures ANOVA | n=3 with ≥4 time points |
| Dose-response | Regression analysis | n=3 with ≥5 concentrations |
Calibration curve implementation: For absolute quantification, develop a standard curve using recombinant YKL118W protein at known concentrations.
Normalization strategy validation: Confirm that selected housekeeping proteins remain stable under your experimental conditions by testing multiple candidates .
Essential controls and validation techniques include:
Genetic controls:
YKL118W deletion strain (negative control)
YKL118W overexpression strain (positive control)
Testing in multiple genetic backgrounds
Antibody validation controls:
Peptide competition assay to confirm specificity
Secondary antibody-only control to check background
Isotype control to identify non-specific binding
Technical validation:
Demonstrate reproducibility across ≥3 biological replicates
Show consistent results using different detection methods (fluorescence vs. chemiluminescence)
Confirm findings with orthogonal techniques (e.g., mass spectrometry)
Result verification table:
| Validation Approach | Expected Outcome | Alternative If Failed |
|---|---|---|
| Genetic knockout control | No signal | Use epitope-tagged version |
| Peptide competition | Signal elimination | Try antibody to different epitope |
| Size verification | Band at predicted MW | Check for post-translational modifications |
| Subcellular fractionation | Enrichment in expected compartment | Confirm localization with fluorescent tagging |
Transparent reporting: Include complete methodological details including antibody catalog number, lot number, dilution, incubation conditions, and detection method specifications .
When facing contradictory results between antibody-based detection and other methods:
Systematic discrepancy analysis:
Document all differences in sample preparation between methods
Examine whether protein modifications might affect different detection methods differently
Consider time-dependent changes in protein expression or modification
Method-specific limitations assessment:
| Method | Common Limitations | Verification Approach |
|---|---|---|
| Antibody detection | Epitope masking, cross-reactivity | Test multiple antibodies to different epitopes |
| Mass spectrometry | Ionization bias, peptide coverage | Target multiple peptides from the protein |
| RNA-based methods | Post-transcriptional regulation | Perform polysome profiling |
| Fluorescent protein fusion | Interference with function | Test N and C-terminal tags |
Integrated data resolution strategy:
Weight evidence based on methodological strengths
Design experiments that can explain the discrepancies
Use mathematical modeling to reconcile apparently contradictory data
Consider biological explanations (e.g., different protein isoforms)
Independent laboratory verification: For persistent discrepancies, collaborate with other research groups to test both methods under standardized conditions .
Integrating YKL118W antibody detection with other techniques:
Sequential analysis workflows:
| Primary Technique | Complementary Method | Research Insight Gained |
|---|---|---|
| ChIP with YKL118W antibody | RNA-seq | Correlation between binding and expression |
| Immunoprecipitation | Mass spectrometry | Interaction partners identification |
| Western blotting | Polysome profiling | Translation efficiency correlation |
| Immunofluorescence | Live-cell imaging | Static vs. dynamic localization |
Multi-omics integration approach:
Create temporal profiles combining proteomics, transcriptomics, and metabolomics
Develop computational methods to correlate YKL118W levels with global cellular changes
Use network analysis to position YKL118W in functional pathways
Single-cell analysis integration:
Combine flow cytometry using YKL118W antibody with single-cell RNA-seq
Employ microfluidics platforms for correlating protein levels with phenotypic outputs
Develop split-pool barcoding strategies for high-throughput studies
Spatial biology application:
Systems biology approaches utilizing YKL118W antibody data:
Regulatory network reconstruction:
Integrate ChIP-seq data with transcriptomics to identify direct targets
Use dynamic antibody-based measurements following perturbations to infer network topology
Employ Boolean or Bayesian network modeling to predict system behavior
Quantitative modeling frameworks:
| Modeling Approach | Data Requirements | Biological Insights |
|---|---|---|
| Ordinary differential equations | Time-course protein levels | Reaction kinetics and dynamics |
| Flux balance analysis | Steady-state protein levels | Metabolic impact assessment |
| Agent-based modeling | Single-cell protein distributions | Emergent population behaviors |
| Machine learning integration | Multi-parametric data | Pattern identification and prediction |
Multi-scale integration strategy:
Connect molecular-level YKL118W data to cellular phenotypes
Develop hierarchical models linking protein function to population-level behaviors
Implement sensitivity analysis to identify key parameters in system response
Comparative systems approach:
To determine functional relationships between YKL118W and other proteins:
Genetic interaction mapping:
Perform synthetic genetic array (SGA) analysis with ykl118w mutants
Conduct dosage suppression screens to identify compensatory mechanisms
Implement CRISPR interference screens in YKL118W backgrounds
Protein interaction determination:
| Interaction Method | Strength | Limitation | Result Interpretation |
|---|---|---|---|
| Co-immunoprecipitation | Detects stable complexes | May miss transient interactions | Direct or indirect physical association |
| Proximity labeling (BioID) | Captures neighborhood proteins | Spatial resolution limited | Proximity but not necessarily direct interaction |
| Two-hybrid assays | High-throughput capability | Prone to false positives | Potential for direct interaction |
| FRET/BRET analysis | Real-time in vivo detection | Requires fluorescent tags | Direct physical interaction within 10nm |
Functional redundancy assessment:
Create single and double knockout/knockdown strains
Perform complementation analysis with homologous genes
Conduct domain swapping experiments to identify functional regions
Pathway positioning experiments:
Emerging applications of YKL118W antibody include:
Single-molecule detection approaches:
Super-resolution microscopy with YKL118W antibody for nanoscale localization
Single-molecule pull-down for analyzing complex stoichiometry
Optical tweezers combined with antibody detection for force-dependent interactions
High-throughput adaptation strategies:
| Platform | Application | Technical Advancement |
|---|---|---|
| Microfluidic antibody arrays | Parallel protein detection | Reduced sample volume, increased throughput |
| Automated western workflows | Standardized quantification | Improved reproducibility and statistical power |
| Droplet-based single-cell analysis | Cell-to-cell variability | Correlation of protein levels with phenotypic heterogeneity |
| Organ-on-chip systems | Context-dependent function | Testing protein function in multicellular environments |
Temporal dynamics investigation:
Develop real-time reporters based on antibody-derived binding domains
Implement optogenetic control of YKL118W combined with antibody detection
Create microfluidic platforms for pulsed perturbations with continuous monitoring
Structural biology integration:
Integration of YKL118W antibody with advanced imaging:
Super-resolution microscopy applications:
STORM imaging using directly-labeled primary antibodies for improved localization precision
Expansion microscopy to physically magnify structures for conventional microscopes
Lattice light-sheet microscopy for rapid 3D visualization with reduced photodamage
Multiparametric imaging strategies:
| Imaging Approach | Technical Requirements | Research Benefit |
|---|---|---|
| Multiplexed ion beam imaging | Metal-conjugated antibodies | >40 parameters simultaneously |
| Cyclic immunofluorescence | Antibody elution/reapplication | 20-40 protein targets in single cells |
| Mass cytometry imaging | Rare earth metal-labeled antibodies | High-dimensional spatial proteomics |
| Hyperspectral imaging | Spectrally distinct fluorophores | Simultaneous tracking of multiple targets |
Live-cell adaptation methods:
Develop antibody fragments or nanobodies against YKL118W for intracellular expression
Implement split-protein complementation for visualization of protein interactions
Create FRET-based biosensors using antibody-derived binding domains
Correlative microscopy approach:
Future research directions for YKL118W characterization:
Comprehensive functional annotation:
Apply CRISPR base editing for point mutation libraries
Develop deep mutational scanning approaches with antibody-based selection
Implement domain-focused random mutagenesis with functional screening
Environmental response mapping:
| Environmental Condition | Analytical Approach | Expected Insight |
|---|---|---|
| Nutrient limitation | Quantitative Western blotting | Stress-responsive regulation |
| Temperature shifts | Time-resolved immunodetection | Adaptation mechanism |
| Chemical perturbations | Chemical-genetic profiling | Pathway involvement |
| Chronological aging | Single-time point cohort analysis | Longevity contribution |
Technology development opportunities:
Create biosensors derived from YKL118W-specific binding domains
Develop targeted protein degradation approaches using antibody-based recognition
Implement spatially-resolved proteomics with YKL118W as a model protein
Translational research connections: